Lifevantage Net Profit Margin 2010-2025 | LFVN

Lifevantage net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Lifevantage Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $0.22B $0.01B 4.05%
2024-12-31 $0.21B $0.01B 3.77%
2024-09-30 $0.20B $0.00B 2.04%
2024-06-30 $0.20B $0.00B 1.50%
2024-03-31 $0.21B $0.00B 1.95%
2023-12-31 $0.21B $0.00B 1.42%
2023-09-30 $0.21B $0.00B 1.41%
2023-06-30 $0.21B $0.00B 1.40%
2023-03-31 $0.21B 0 0.00%
2022-12-31 $0.21B 0 0.00%
2022-09-30 $0.21B $0.00B 0.49%
2022-06-30 $0.21B $0.00B 1.46%
2022-03-31 $0.21B $0.01B 4.29%
2021-12-31 $0.21B $0.01B 4.72%
2021-09-30 $0.22B $0.01B 6.39%
2021-06-30 $0.22B $0.01B 5.88%
2021-03-31 $0.23B $0.01B 5.33%
2020-12-31 $0.23B $0.01B 5.24%
2020-09-30 $0.23B $0.01B 5.19%
2020-06-30 $0.23B $0.01B 5.17%
2020-03-31 $0.23B $0.01B 5.24%
2019-12-31 $0.23B $0.01B 5.24%
2019-09-30 $0.23B $0.01B 3.98%
2019-06-30 $0.23B $0.01B 3.54%
2019-03-31 $0.22B $0.01B 3.13%
2018-12-31 $0.22B $0.01B 3.20%
2018-09-30 $0.21B $0.01B 2.86%
2018-06-30 $0.20B $0.01B 2.96%
2018-03-31 $0.20B $0.00B 1.50%
2017-12-31 $0.19B $0.00B 0.52%
2017-09-30 $0.19B $0.00B 0.52%
2017-06-30 $0.20B $0.00B 0.50%
2017-03-31 $0.20B $0.00B 1.49%
2016-12-31 $0.21B $0.00B 1.88%
2016-09-30 $0.22B $0.01B 2.78%
2016-06-30 $0.21B $0.01B 2.91%
2016-03-31 $0.20B $0.00B 2.02%
2015-12-31 $0.19B $0.00B 2.14%
2015-09-30 $0.18B $0.00B 1.64%
2015-06-30 $0.19B $0.01B 3.68%
2015-03-31 $0.20B $0.01B 4.48%
2014-12-31 $0.21B $0.01B 4.74%
2014-09-30 $0.22B $0.01B 5.58%
2014-06-30 $0.21B $0.01B 4.67%
2014-03-31 $0.21B $0.01B 3.81%
2013-12-31 $0.21B $0.01B 4.39%
2013-09-30 $0.21B $0.01B 2.91%
2013-06-30 $0.21B $0.01B 3.37%
2013-03-31 $0.20B $0.01B 5.97%
2012-12-31 $0.19B $0.00B 2.14%
2012-09-30 $0.16B $0.01B 8.18%
2012-06-30 $0.13B $0.01B 10.32%
2012-03-31 $0.10B $-0.04B -40.63%
2011-12-31 $0.07B $-0.04B -62.86%
2011-09-30 $0.05B $-0.05B -92.31%
2011-06-30 $0.04B $-0.05B -134.21%
2011-03-31 $0.03B $-0.01B -33.33%
2010-12-31 $0.02B $-0.01B -35.00%
2010-09-30 $0.02B $-0.01B -86.67%
2010-06-30 $0.01B $-0.01B -118.18%
2010-03-31 $0.01B $-0.01B -144.44%
2009-12-31 $0.01B $-0.01B -114.29%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.163B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.805B 21.44
Becton Dickinson (BDX) United States $51.260B 12.69
Cardinal Health (CAH) United States $38.083B 19.94
Straumann Holding AG (SAUHY) Switzerland $20.857B 0.00
West Pharmaceutical Services (WST) United States $15.151B 31.76
Cooper (COO) United States $14.525B 18.72
Align Technology (ALGN) United States $13.828B 27.45
Henry Schein (HSIC) United States $8.411B 14.43
Merit Medical Systems (MMSI) United States $4.906B 23.72
DENTSPLY SIRONA (XRAY) United States $3.125B 9.33
CONMED (CNMD) United States $1.474B 11.03
STAAR Surgical (STAA) United States $0.860B 0.00
Pro-Dex (PDEX) United States $0.151B 16.50